Fingerprint
Dive into the research topics of 'Patient-reported outcomes in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer receiving olaparib versus chemotherapy in the OlympiAD trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically